PP13. PHASE II STUDY OF THE SAFETY AND EFFICACY OF INFLIXIMAB IN GIANT CELL ARTERITIS (GCA): 22 WEEK INTERIM ANALYSIS.

Autor: G. S. Hoffman, M. C. Cid, C. M. Weyand, J. H. Stone, K. E. Rendt, C. Salvarani, P. A. Merkel, W. Xu, S. Visvanathan, M. U. Rahman
Zdroj: Rheumatology; Mar2005, Vol. 44 Issue 3, piii18-iii18, 1p
Databáze: Complementary Index